Aastrom Biosciences Inc. (ASTM) announced the closing of underwritten public offering, raising approximately $12.4 million in net proceeds from the sale of the units, including the partially exercised option of the over-allotment, after underwriting discounts and commissions and other offering expenses. The offering included the sale of 52,077,100 units in total at a public offering price of $0.26 per unit.
The company plans to use the net proceeds for general corporate purposes, including conducting operations and continuing to conduct clinical development programs.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.